Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1
A new study shows possible clinical benefits of intraperitoneal paclitaxel for gastric cancer. Published in the Journal of Clinical Oncology, An American... Read More
Gastric cancer screening in high-risk groups cost-effective
A new modeling study in Gastroenterology shows gastric cancer screening in the US could be cost-effective in high-risk racial and ethnic groups.... Read More
Endoscopic Surveillance Detects Early Gastric Cancer
Published in Gut, researchers in the Netherlands got some interesting insight in a study using endoscopy to catch gastric cancer at an... Read More
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
A new study published in The Lancet finds Keytruda, the PD-1 antibody pembrolizumab, may offer a better safety profile but does not... Read More
Breath Test Potential for Gastric Cancer Diagnosis
A study in JAMA Oncology suggests the potential of breath analysis as a noninvasive tool in diagnosing esophagogastric cancer. Read the full... Read More
Magnetically controlled capsule gastroscopy feasible for gastric cancer screening
Researchers in Shanghai found magnetically controlled capsule gastroscopy may be a safe, noninvasive, easy to perform and effective way to screen for... Read More
Phase 3 study comparing triplet chemotherapy with S-1 and cisplatin plus docetaxel versus doublet chemotherapy with S-1 and cisplatin for advanced gastric cancer (JCOG1013)
Presented at the American Society of Clinical Oncology annual conference, researchers from Japan found doublet chemo with S-1 and cisplatin (CS) first-line... Read More
‘Prehab’ Boosts Fitness Before Upper GI Surgery
A small randomized trial found esophagogastric cancer patients who were prehabilitated before having surgery had significantly better functional capacity before and after... Read More
Taiho Oncology and Servier to Present Data on LONSURF® (trifluridine and tipiracil) and Key Investigational Compound TAS-120 at ESMO 20th World Congress on Gastrointestinal Cancer 2018
Good results from the drug Lonsurf for treating metastatic gastric cancer in a phase 3 trial are being presented this week at... Read More
Daiichi Sankyo Presents Long-Term Phase 1 Results of Antibody Drug Conjugate DS-8201 in Patients with HER2-Expressing Breast, Gastric and Other Solid Cancers at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
New research presented at the American Society of Clinical Oncology annual conference this month shares the comprehensive research program is underway to... Read More
